Skip to main content

Table 2 Association of fibrinogen and Lp(a) categories with clinical outcomes

From: Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

Risk factor

Tertile/range

KM rates(%)

Hazard ratio

(95% CI)

p value

Lp(a) categories

Total (mg/dL)

   

 < 0.001

 

Lp(a)-L (< 10)

3.5

Reference

 
 

Lp(a)-M (10–29.9)

5.3

1.468

1.142–1.886

0.003

 

Lp(a)-H (≥ 30)

5.6

1.580

1.227–2.033

 < 0.001

Fibrinogen categories

Total (g/L)

   

 < 0.001

 

Fib-L(< 2.84)

4.0

Reference

 
 

Fib-M(2.85–3.42)

4.4

1.123

0.867–1.455

0.380

 

Fib-H(≥ 3.43)

6.1

1.631

1.282–2.074

 < 0.001

Combined categories

Total

   

 < 0.001

 

G1(Lp(a)-L + Fib-L)

3.3

Reference

 
 

G2(Lp(a)-L + Fib-M)

3.5

1.091

0.697–1.707

0.704

 

G3(Lp(a)-L + Fib-H)

4.0

1.234

0.771–1.977

0.381

 

G4(Lp(a)-M + Fib-L)

4.1

1.164

0.741–1.828

0.509

 

G5(Lp(a)-M + Fib-M)

4.9

1.406

0.914–2.162

0.121

 

G6(Lp(a)-M + Fib-H)

7.0

2.135

1.446–3.152

 < 0.001

 

G7(Lp(a)-H + Fib-L)

4.8

1.348

0.849–2.140

0.206

 

G8(Lp(a)-H + Fib-M)

5.4

1.578

1.026–2.426

0.038

 

G9(Lp(a)-H + Fib-H)

7.2

2.215

1.506–3.257

 < 0.001

  1. Data are expressed as HR (95% CI). L low, M medium, H high